Susquehanna International Group’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Sell |
254,018
-1,479,063
| -85% | -$7.5M | ﹤0.01% | 2877 |
|
|
2025
Q1 | $5.23M | Buy |
1,733,081
+945,239
| +120% | +$2.85M | ﹤0.01% | 1168 |
|
|
2024
Q4 | $2.85M | Buy |
787,842
+654,613
| +491% | +$2.37M | ﹤0.01% | 1570 |
|
|
2024
Q3 | $234K | Buy |
+133,229
| New | +$234K | ﹤0.01% | 4616 |
|
|
2023
Q3 | – | Sell |
-46,634
| Closed | -$101K | – | 6506 |
|
|
2023
Q2 | $101K | Buy |
+46,634
| New | +$101K | ﹤0.01% | 5000 |
|
|
2022
Q4 | – | Sell |
-45,542
| Closed | -$137K | – | 6882 |
|
|
2022
Q3 | $137K | Sell |
45,542
-997
| -2% | -$3K | ﹤0.01% | 5088 |
|
|
2022
Q2 | $132K | Buy |
+46,539
| New | +$132K | ﹤0.01% | 4860 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6634 |
|
|
2021
Q4 | – | Sell |
-81,781
| Closed | -$743K | – | 6549 |
|
|
2021
Q3 | $743K | Buy |
81,781
+70,942
| +655% | +$645K | ﹤0.01% | 3154 |
|
|
2021
Q2 | $53K | Buy |
+10,839
| New | +$53K | ﹤0.01% | 5155 |
|
|
2020
Q2 | – | Sell |
-10,268
| Closed | -$29K | – | 5052 |
|
|
2020
Q1 | $29K | Buy |
+10,268
| New | +$29K | ﹤0.01% | 4293 |
|
|
2019
Q1 | – | Sell |
-7,083
| Closed | -$49K | – | 4706 |
|
|
2018
Q4 | $49K | Buy |
7,083
+1,878
| +36% | +$13K | ﹤0.01% | 3333 |
|
|
2018
Q3 | $59K | Buy |
+5,205
| New | +$59K | ﹤0.01% | 3051 |
|
|
2017
Q2 | – | Sell |
-1,381
| Closed | -$68K | – | 4479 |
|
|
2017
Q1 | $68K | Buy |
+1,381
| New | +$68K | ﹤0.01% | 3023 |
|